• Last week, Congress passed S. 3187, the Food and Drug Administration Safety and Innovation Act. The Act, which passed in the Senate on a 92-4 vote, will require the development of strategies to promote the deployment of health information technology, including mobile applications. The FDA, in consultation with the FCC and the national coordinator for health information technology, is required to complete a report within 18 months “that contains a proposed strategy and recommendations on an appropriate, risk-based regulatory framework pertaining to health information technology, including mobile medical applications, that promotes innovation, protects patient safety, and avoids regulatory duplication.” S. 3187 also allows the formation of a working group of outside stakeholders to provide input for the report. To read the statute, click here.